Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma.
Overview
publication date
- October 31, 2023
published in
- British journal of haematology Journal
Research
keywords
- Hodgkin Disease
- Lymphoma, Non-Hodgkin
Identity
Digital Object Identifier (DOI)
- 10.1111/bjh.19178
PubMed ID
- 37905372